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for stone formation for the concentration of other urine factorsTwenty-four–hour urine chemistries and the risk of kidney
within the different cohorts.stones among women and men.
Conclusions. The traditional definitions of normal 24-hourBackground. Results of a 24-hour urine collection are inte-
urine values need to be reassessed, as a substantial proportiongral to the selection of the most appropriate intervention to
of controls would be defined as abnormal, and the associationprevent kidney stone recurrence. However, the currently ac-
with risk of stone formation may be continuous rather than di-cepted definitions of normal urine values are not firmly sup-
chotomous. The 24-hour urine chemistries are important for pre-ported by the literature. In addition, little information is avail-
able about the relationship between risk of stone formation dicting risk of stone formation, but the significance and the magni-
and the levels of urinary factors. Unfortunately, the majority tudes of the associations appear to differ by age and gender.
of previous studies of 24-hour urine chemistries were limited
by the inclusion of recurrent stone formers and poorly defined
controls.
Results of the 24-hour urine collection are integral toMethods. We obtained 24-hour urine collections from 807
the selection of the most appropriate intervention tomen and women with a history of kidney stone disease and
239 without a history who were participants in three large prevent kidney stone recurrence [1]. Nevertheless, data
ongoing cohort studies: the Nurses’ Health Study I (NHS I; that provide an accurate description of the 24-hour urine
mean age of 61 years), the Nurses’ Health Study II (NHS II;
values in individuals with and without a history of kidneymean age of 42 years), and the Health Professionals Follow-
stone formation are scarce. Accordingly, distributions ofup Study (HPFS; mean age of 59 years).
Results. Mean 24-hour urine calcium excretion was higher values for the 24-hour urine chemistries, the frequencies
and urine volume was lower in cases than controls in NHS I of urinary abnormalities, and the associations of individ-
(P # 0.01), NHS II (P # 0.13) and HPFS (P # 0.01), but urine ual urine factors with risk of stone formation for individ-oxalate and citrate did not differ. Among women, urine uric
uals with and without a history of kidney stone formationacid was similar in cases and controls but was lower in cases
should be useful.in men (P 5 0.06). The frequency of hypercalciuria was higher
among the cases in NHS I (P 5 0.26), NHS II (P 5 0.03), Previous reports of mean 24-hour urine values were
and HPFS (P 5 0.02), but 27, 17, and 14% of the controls, based on studies of recurrent stone formers or a mixture
respectively, also met the definition of hypercalciuria. The fre-
of first-time and recurrent stone formers. However, indi-quency of hyperoxaluria did not differ between cases and con-
viduals with recurrent stone formation may be more likelytrols, but was three times more common among men compared
with women. After adjusting for the other urinary factors, the to have extreme urinary values associated with their
relative risk of stone formation increased with increasing urine stone activity. In addition, these reports often did not
calcium levels and concentration in all three cohorts but not include a control group or used only a small or historical
in a linear fashion. Compared with individuals with a urine
group of controls. Little information is available fromcalcium concentration of ,75 mg/L, the relative risk of stone
first-time stone formers [2] or well-defined controls [3].formation among those with a urine calcium concentration of
$200 mg/L for NHS I was 4.34 (95% CI, 1.59 to 11.88), for The currently accepted definitions of normal urine
NHS II was 51.09 (4.27 to 611.1), and for HPFS was 4.30 (1.71 values are not firmly supported by the literature. For
to 10.84). There was substantial variation in the relative risks example, the generally accepted definitions of hypercal-
ciuria are $250 mg/day for women and $300 mg/day
for men. However, when considering the risk of crystalKey words: nephrolithiasis, risk of renal stones, stone formers, crystal
formation, hypercalciuria, calcium excretion. formation in the urine, there is no clear justification to
differentiate normal ranges for calcium excretion ac-Received for publication August 15, 2000
cording to gender. The imprecise categorization of uri-and in revised form November 15, 2000
Accepted for publication January 15, 2001 nary excretion by an individual as either “normal” or
“abnormal” can lead to under-recognition of metabolicÓ 2001 by the International Society of Nephrology
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abnormalities and a missed opportunity for treatment. Urine collection procedure
The relationship between risk of stone formation and Beginning in 1994, we requested 24-hour urine sam-
the levels of urinary factors likely varies in a graded fash- ples from NHS I and HPFS participants who had an
ion, and thus, dichotomization into normal and abnormal incident kidney stone diagnosed in 1988 or later and a
may not be appropriate. Therefore, it is essential to quan- random sample of controls. Participants were not eligible
titate the risk of stone formation according to several if they were .70 years of age in HPFS or .65 years in
levels of 24-hour urine values. Clearly, better definitions NHS I or had a history of cancer or cardiovascular dis-
of “abnormal” values and their relative importance in ease. In 1995, we requested 24-hour urine collections
stone formation risk are needed based on the distribu- from a sample of NHS II cases diagnosed after 1991 and
tions of the 24-hour urine results in a well-characterized a small sample of randomly selected controls.
group of stone formers and appropriate controls. Among the eligible cases, 79% of HPFS subjects, 72%
To address these issues, 24-hour urine collections were of the NHS I subjects, and 73% of the NHS II subjects
obtained from 807 men and women with a history of kidney agreed to participate. Of those who agreed to participate,
stone disease and 239 without a history who were partici- 82% of subjects in HPFS, 82% in NHS I, and 72% in
pants in three large ongoing cohort studies: Nurses’ NHS II actually completed the collections. Overall, the
Health Study I (NHS I), Nurses’ Health Study II (NHS II), urine collection rate from all eligible cases was 65% in
and Health Professionals Follow-up Study (HPFS). HPFS, 59% in NHS I, and 53% in NHS II.
From the randomly selected HPFS controls, 61%
agreed to participate, and 81% of those completed theMETHODS
collection. The participation and completion rates in con-
Study population trols for NHS I were 57 and 67% and for NHS II 45
Nurses’ Health Study I. In 1976, 121,700 female regis- and 72%. Overall, urine was obtained from 49% of the
tered nurses who were 30 to 55 years of age and resided in controls in HPFS, 38% in NHS I, and 32% in NHS II.
1 of 11 U.S. states completed and returned the initial ques- There were no substantial differences between those
tionnaire. These women constitute the NHS I cohort [4]. subjects who did collect urine compared with those who
Nurses’ Health Study II. In 1989, a second cohort of did not according to age, body mass index, and intake
116,671 female registered nurses from 15 states aged 25 of dietary calcium, sodium, and animal protein. How-
to 42 completed a baseline questionnaire. These women ever, the frequency of use of calcium supplements was
constituted the NHS II cohort [5]. 9% higher among those who did collect urine.
Health Professionals Follow-up Study. In 1986, 51,529 Results were received for 350 cases and 130 controls
men aged 40 to 75 answered a detailed mailed question- in NHS I, 183 cases and 32 controls in NHS II, and 380
naire. This group of men, from all 50 states, included cases and 147 controls in HPFS. To exclude subjects with
dentists, optometrists, osteopathic physicians, pharma- obviously incomplete collections, we limited the analysis
cists, podiatrists, and veterinarians [6]. to those participants whose 24-hour urine creatinine
All three cohorts were followed using biennial mailed value was at least 800 mg for the women and at least
questionnaires that ask about lifestyle practices and other 1200 mg for the men. The percentages of the available
exposures of interest, as well as newly diagnosed disease. results for cases and controls that met these criteria were,
The average follow-up for all three cohorts is .90%. respectively, 85 and 76% for NHS I, 92 and 91% for
NHS II, and 90 and 75% in HPFS.
Ascertainment of kidney stones The 24-hour urine collections were performed using
Beginning in 1992 for NHS I, 1991 for NHS II, and the system provided by Mission Pharmacal (San Anto-
1986 for HPFS, the biennial questionnaires inquired nio, TX, USA). To those subjects who agreed to partici-
whether the participant had ever been diagnosed with a pate, we sent a kit containing all necessary supplies,
kidney stone. If the participant reported that a kidney including a 4 L jug with a lithium-impregnated sponge
stone had been diagnosed, we mailed a supplementary attached to the bottom. The jugs also contained preserva-
questionnaire to confirm the diagnosis and to ascertain tive to prevent bacterial growth. To assist in urine collec-
the date of occurrence, the symptoms, a history of other tion, female participants were sent specially designed
relevant medical conditions, and the type of stone. The “hats” and male participants were sent urinals. Upon
average response rate to the supplementary question- completion of the collection, participants poured sam-
naire in all three cohorts was .90%. To confirm the ples into two small vials, one of which contained acid
validity of the self-report, we obtained the medical re- preservative. The vials were returned to Mission Phar-
cords from a random sample of 60 of the confirmed cases macal in a prepaid self-addressed Federal Express
in HPFS and 90 in NHS I. The medical records confirmed mailer. The concentration of the lithium was used to
calculate the total volume of the collection. The urinethe diagnosis in $97% of the cases.
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Table 1. Characteristics of participants from three cohort studies (NHS I, NHS II, HPFS) according to case status
NHS I NHS II HPFS
Case Control Case Control Case Control
Variable (N 5 297) (N 5 99) (N 5 169) (N 5 30) (N 5 341) (N 5 110)
Agea years 60.4 (6.7) 61.9 (6.2) 41.6 (4.7) 42.9 (3.7) 57.8 (7.0) 60.8 (6.6)
Weight kg 74.9 (15.7) 72.3 (14.6) 73.8 (18.9) 77.9 (16.7) 84.0 (12.2) 86.7 (13.5)
BMI kg/m2 28.0 (5.7) 26.5 (5.1) 27.4 (6.6) 28.4 (5.8) 26.2 (3.5) 27.0 (3.6)
Family history % NA NA NA NA 22% 18%
Values for variables are means (standard deviation) except for family history, which is percent. NA, not available.
a Age at urine collection
measurements were performed by Mission Pharmacal within the respective cohorts. Women in NHS II were
without knowledge of the individuals’ exposure status. more than 15 years younger than the women in NHS I
and the men in HPFS. A family history of stone disease,
Analytic procedures used for the urine measurements only available for HPFS, was slightly more frequent in
Calcium and magnesium were measured by an atomic cases (22%) than controls (18%). A substantially higher
absorption spectrophotometer. Creatinine, uric acid, cit- frequency of a family history of kidney stones was ob-
rate, and phosphorus were measured by a Cobas centrif- served in the controls who performed the urine collection
ugal analyzer. Oxalate was analyzed by ion chromatogra- (18%) compared with the general HPFS population
phy (interassay coefficient of variation was 4.3% and without a personal history of stones (6.4%). In addition,
the intra-assay was 2.5%). Sodium and potassium were the cases who performed the urine collection had a
determined directly by flame emission photometry. The slightly higher family history frequency (22 vs. 17.2%)
urine pH was measured by a pH electrode. than cases in the general cohort. After excluding men
with a family history, the mean age, weight, and body
Statistical analysis mass index (BMI) did not change substantially.
Categorical variables were compared using the chi- The mean (SD) 24-hour urine values according to case
square test. Logistic regression was used to calculate status are presented in Table 2. The mean calcium excre-
relative risks for being a kidney stone case after adjusting tion was higher in cases than controls in NHS I (P 5
simultaneously for multiple factors. The variables in- 0.01), NHS II (P 5 0.06), and HPFS (P , 0.001). Calcium
cluded simultaneously in the multivariate model were excretion was slightly higher among male compared with
age and 24-hour urinary excretion of calcium, oxalate, female cases, while the means for controls were similar
citrate, uric acid, sodium, magnesium, potassium, creati- among the three cohorts. The mean urine oxalate, uric
nine, and total volume. Clinically reasonable increments acid, sodium, and creatinine were considerably higher
of change were selected for categories of the urinary in men compared with women, but there were no sub-
factors to calculate relative risks. For some of the vari- stantial differences between cases and controls within
ables, slightly different categories were used for men and any cohort. For urine citrate, there were no large gender
women because of the different ranges of values. For or case-control differences. Urine volume was consis-
example, men produce and excrete more creatinine than tently lower in cases compared to controls within each
women; thus, higher categories were selected. If there cohort (NHS I, P 5 0.001; NHS II, P 5 0.13; HPFS, P 5
were sufficient numbers of cases and controls in the high-
0.009), and in particular, NHS II cases had the lowest
est category, an additional category was created. For
mean urine volume among the three cohorts. Urine po-example, in NHS I and II $50 mg/day was used as the
tassium was highest in men and lowest in the youngerhighest category for oxalate, but in HPFS, we created a
women (NHS II). In NHS I and HPFS, the cases hadhigher category $60 mg/day. The P values for trend in
significantly lower urine potassium than controls. Thethe multivariate models were calculated after assigning
urine values for cases and controls in HPFS did notthe median values to the categories. We calculated 95%
change substantially after excluding those subjects withconfidence intervals for all relative risks. All P values
a family history of kidney stones (data not shown).are two tailed.
The mean (SD) 24-hour urine values according to
body weight categories were also examined (data not
RESULTS shown). Mean urine calcium, oxalate, and uric acid in-
creased with increasing weight. In similar weight catego-Characteristics of participants from the three cohorts
ries, urine calcium did not differ between males andaccording to case status are presented in Table 1. The
mean age and weight were similar for cases and controls females. However, urine oxalate and uric acid were sub-
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Table 2. Mean (SD) 24-hour urine values from participants in three cohort studies (NHS I, NHS II, HPFS) according to case status
NHS I NHS II HPFS
Case Control Case Control Case Control
Variable (N 5 297) (N 5 99) (N 5 169) (N 5 30) (N 5 341) (N 5 110)
Calcium mg 226 (116)a 192 (113) 231 (108) 186 (120) 241 (118)a 198 (101)
Oxalate mg 34 (11) 34 (12) 33 (9) 31 (8) 46 (14) 44 (12)
Uric acid mg 522 (190) 515 (173) 566 (157) 569 (169) 701 (249) 744 (196)
Citrate mg 683 (338) 714 (345) 722 (270) 717 (304) 708 (311) 682 (252)
pH units 5.9 (0.5)a 6.0 (0.5) 5.9 (0.4) 5.9 (0.3) 5.8 (0.5) 5.8 (0.4)
Total volume L 1.76 (0.70)a 2.15 (0.91) 1.51 (0.67) 1.75 (0.79) 1.66 (0.64)a 1.87 (0.76)
Sulfate mg 20 (7) 20 (7) 18 (6) 19 (6) 25 (8) 25 (7)
Phosphate mg 871 (265) 823 (283) 862 (277) 855 (313) 1174 (329) 1134 (247)
Magnesium mg 107 (44) 110 (40) 102 (35) 115 (36) 133 (45) 129 (36)
Sodium mEq 157 (70) 149 (57) 164 (68) 151 (70) 193 (73) 195 (75)
Potassium mEq 63 (23)a 71 (24) 52 (19) 56 (22) 78 (25)a 85 (26)
Ammonium mg 31 (13) 30 (13) 33 (11) 31 (8) 37 (14) 37 (13)
Creatinine mg 1138 (266)a 1067 (209) 1148 (208) 1154 (216) 1747 (360)b 1675 (319)
a P # 0.01 for case-control comparison within the cohort
b P # 0.05 for case-control comparison within the cohort
Table 3. Frequency (%) of urinary abnormalities in participants in three cohort studies (NHS I, NHS II, HPFS) according to case status
NHS I NHS II HPFS
Case Control Case Control Case Control
Abnormality (N 5 297) (N 5 99) (N 5 169) (N 5 30) (N 5 341) (N 5 110)
Hypercalciuria
F $250 mg/day
M $300 mg/day 33% 27% 38%a 17% 25%a 14%
Hyperoxaluria
$45 mg/day 13 14 11 7 47 43
Hyperuricosuria
F $750 mg/day
M $800 mg/day 9 8 13 17 29a 40
Hypocitraturia
#320 mg/day 11 9 5 3 8 4
Low urine volume
#1 L/day 13 7 25 20 12 8
F denotes female, M denotes male.
a P # 0.05 for case compared with control
stantially higher in males compared with females in each was significantly less common among male cases (P 5
0.04). Compared with female cases, hypercalciuria wasweight category.
The frequencies of urinary abnormalities based on the significantly less common among the male cases (P #
0.04). In addition, hyperoxaluria and hyperuricosuriagenerally accepted definitions are presented according
to case status in Table 3. Among women, hypercalciuria were more common among HPFS cases and controls
compared to the female cohorts (P , 0.01 for all compar-was the most common abnormality. Hypercalciuria was
significantly more common among the cases than the isons).
We examined the correlations between the urinarycontrols in NHS II (P 5 0.03) but not in NHS I (P 5
0.26). There were no significant differences within the factors according to cohort and case status and found
that the highest correlations were those that includedfemale cohorts between cases and controls for the fre-
quencies of hyperoxaluria, hyperuricosuria, hypocitratu- creatinine. The highest correlations in the cases were be-
tween creatinine and uric acid for all three cohorts (r $ria, or low urine volume.
Among men in HPFS, the most common abnormalities 0.53, P , 0.001). Among the controls, the highest correla-
tions were between creatinine and oxalate in HPFS (r 5were hyperoxaluria, hyperuricosuria, and hypercalciuria
(Table 3). Hypercalciuria was significantly more com- 0.55, P , 0.001), uric acid in NHS I (r 5 0.62, P ,
0.001), and calcium in NHS II (r 5 0.59, P , 0.001).mon among the cases than controls in HPFS (P 5 0.02).
The frequencies of hyperoxaluria, hypocitraturia, and The correlations that did not include creatinine were
generally r , 0.45.low urine volume did not differ significantly between
male cases and controls. Unexpectedly, hyperuricosuria The multivariate relative risks for nephrolithiasis ac-
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cording to categories of absolute amounts of 24-hour quencies of urinary abnormalities differed by gender and
age, and abnormalities were relatively common evenurinary excretion are shown in Table 4. The risk of stone
formation was significantly increased for urine calcium among controls. The frequency of hypercalciuria was
less common in first-time stone formers compared with$200 mg/day in NHS I and NHS II and $250 mg/day in
HPFS, but the risk continued to increase with increasing reports from recurrent stone formers [2]. Important inde-
pendent urinary predictors in terms of absolute amountsurine calcium only in NHS II. Urine oxalate was margin-
ally associated with risk in NHS II (P for trend 5 0.11) that were positively associated with risk of nephrolithia-
sis in one or more cohorts were calcium and creatinine.and HPFS (P for trend 5 0.12) but not in NHS I (P for
trend 5 0.59). Uric acid was inversely associated with Urinary factors inversely associated with risk were uric
acid, magnesium, and total volume. When the concentra-risk in HPFS (P for trend 5 0.009) but not in the female
cohorts. Potassium was marginally inversely associated tion of factors was examined, urine oxalate concentration
was also associated with increased risk, and creatininewith risk in HPFS (P for trend 5 0.11) but not in NHS I
or NHS II. Citrate and sodium excretion were not associ- was no longer significantly associated with risk. The mag-
nitude and significance of many of these associationsated with risk of stone formation. Magnesium was associ-
ated with a lower risk in only NHS II (P for trend 5 varied by gender and age.
Notably, 24-hour uric acid excretion was inversely as-0.005), and creatinine was associated with increased risk
in NHS I (P for trend 5 0.02; data not shown). sociated with risk in men. It is unclear why in our male
cohort hyperuricosuria was more common among con-The multivariate relative risks for nephrolithiasis ac-
cording to categories of concentration of 24-hour urinary trols than cases. Uric acid production is related to BMI,
and the mean BMI in the male control group was slightlyfactors are shown in Table 5. The risk of stone formation
increased with increasing urinary calcium concentration higher than the cases. However, after controlling for
BMI, uric acid remained inversely associated with riskin all three cohorts. In addition, the magnitudes of the
relative risks were greater for urinary calcium concentra- in men. A possible explanation for this observation may
be due to the fact that the urine collections were per-tion (Table 5) than the absolute amount of urinary cal-
formed after the stone event. It is conceivable, but un-cium excretion (Table 4). The risk of stone formation
likely, that the cases had reduced their purine intakeincreased with increasing urine oxalate concentration in
prior to the collection, which would lower urine uric acidNHS II (P for trend 5 0.07) and HPFS (P for trend 5
excretion. There is compelling evidence that urine uric0.02). Uric acid concentration was inversely associated
acid is likely to be a risk factor for stone formation [7, 8]with risk only in the male cohort (P for trend 5 0.054).
and may contribute to the higher frequency of stonesMagnesium concentration was inversely associated with
observed in men than women. The results in our studyrisk only in NHS II (P for trend 5 0.002; data not shown).
from first time stone formers are consistent with someSodium concentration was marginally associated with
previous studies [9] but differ from others that reportedincreased risk only in NHS I (P for trend 5 0.11; data
that hyperuricosuria was more common among singlenot shown). Potassium and creatinine concentrations
[2] or recurrent calcium oxalate stone formers [10]. Awere not associated with risk.
randomized controlled trial of allopurinol among recur-The urine collections for the some of the cases were
rent calcium oxalate stone formers demonstrated that allo-performed after the subject had already had a recurrent
purinol decreases stone recurrence rates in patients withstone event. The frequency of kidney stone recurrence
hyperuricosuria, underscoring the importance of highamong the cases before the collection for each cohort
urinary uric acid in calcium oxalate kidney stone forma-was HPFS 14%, NHS I 6%, and NHS II 20%. The
tion [11]. We cannot explain why no increased risk ofexclusion of subjects with stone recurrence did not mate-
stone formation was observed among subjects with veryrially alter the findings.
high urine uric acid excretion. It is possible that allopuri-
nol is only effective in patients with isolated hyperuricos-
DISCUSSION uria or, less likely, that it might have another effect on
These data from three large cohorts challenge many stone formation independent of its effect on urinary uric
commonly held beliefs about 24-hour urine values. Mean acid excretion [8].
urine calcium was consistently higher in cases compared It was also slightly surprising that urine citrate was
with controls. However, mean urine calcium was only not inversely associated with the risk of stone formation.
slightly higher in male cases of nephrolithiasis compared Potassium citrate supplementation reduces the risk of cal-
with female cases and was remarkably similar between cium oxalate stone recurrence in patients with hypocit-
male and female controls. Mean urine oxalate and uric raturia [12] and also possibly in patients with urine citrate
acid were higher in men than women, yet there were no in the normal range [13]. One possible explanation for
substantial differences between cases and controls. Total this apparent discrepancy is that the action of potassium
alkali salts may be mediated through their effect on re-urine volume was similar for men and women. The fre-
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ducing urinary calcium excretion [14] and not solely by considered to be the gold standard analytic method [18].
However, the collection system used in this study doesraising the urine citrate level. Another possibility, al-
though less likely, is that there may be a threshold effect not acidify the urine until the end of the 24-hour collec-
tion so that there could be in vitro conversion of ascor-for urinary citrate.
Although the current definitions of abnormal 24-hour bate to oxalate [19], particularly with very high ascorbate
intake [20]. In support, we found that subjects withurine values are widely accepted, it is unclear how these
cutpoints were selected. Urine excretion rates in previ- $1500 mg/day intake of ascorbate did have higher uri-
nary oxalate levels (data not shown). Nonetheless, evenous studies were measured under a variety of conditions.
There was substantial variability in the selection of study among the participants with ascorbate intake ,250 mg/
day, the mean urine oxalate was still substantially highersubjects, and the cutpoints for the definition of abnormal
were not selected in a consistent manner. These factors than previously reported (data not shown). Although
there were no large differences in mean urinary oxalatelimit the validity and generalizability of the findings of
those studies. between cases and controls, the oxalate concentration
did appear to be an important risk factor for calciumIt is crucial to recognize that the urinary factors are
continuous variables, and their effects on stone forma- oxalate stone formation (Table 5) in NHS II and HPFS.
Possibly, a postprandial spike in urinary oxalate maytion are also likely to be continuous, although not neces-
sarily linear. Accordingly, specific cutpoints for “abnor- have a greater impact on the risk of crystal formation
than the total 24-hour excretion [21].mal” are not appropriate but rather should serve only
as approximate guides. For example, the risk of stone The generalizability of these findings may be slightly
limited. The cohorts are .95% Caucasian, but stonesformation began to increase even within the “normal”
ranges of calcium excretion and urine calcium concentra- occur less frequently in other racial groups. Because
only a single 24-hour urine collection was performed,tion (Tables 4 and 5).
Although the definition of abnormal in the past has the means are likely properly centered, but the standard
deviations may be greater than if multiple collectionsbeen based on the absolute content of the individual
factors in the urine, the risk of stone formation decreases were performed. This may have slightly increased the
observed frequencies of urinary abnormalities. In addi-with increasing urine volume. Therefore, the concentra-
tion of an individual factor appears to be more important tion, errors in the collection procedure could affect the
means and the relative risks observed. Furthermore, wethan simply the absolute amount. In support of this ob-
servation, much larger relative risks for calcium concen- do not know the type of stone each subject formed, but
the vast majority were likely calcium oxalate. Subjectstration than for absolute amounts of calcium adjusted
for total volume were found. In addition, given that men with obvious undercollections were excluded, but some
errors in the completeness of the collections are stilland women have similar 24-hour urine volumes and that
the concentration is the critical determinant of the likeli- likely. The cases performed the urine collection after the
stone event, as would occur in the clinical setting. Thehood of crystal formation in the urine, there appears to
be no known physiological basis for separate definitions subjects were first-time stone formers; thus, very few had
been evaluated, and ,10% were taking medication forof abnormal for men and women. Although principles
of solution chemistry are independent of gender, it does stone prevention at the time of the urine collection. Ex-
clusion of the subjects taking medication did not alterremain possible that the levels of urinary inhibitors do
differ by gender. From the perspective of overall total the findings. Although it may seem surprising that the
mean urine oxalate and uric acid were not substantiallybody balance, the absolute quantities of the urinary fac-
tors remain important, yet the concentration is the more higher in the cases, this is consistent with the findings
from other studies [16, 22]. The individual urinary factorsappropriate paradigm for approaching stone prevention.
The risk of stone formation associated with specific were correlated with the other urinary factors, which may
have decreased the power for detecting true independenturinary factors may vary by age. These observations sug-
gest there may be age-related differences in the action of associations. In addition, there were only 30 controls in
NHS II, limiting our ability to detect associations. Thecertain risk factors. Moreover, the frequencies of urinary
abnormalities differed by age, suggesting that urinary frequency of a family history of kidney stone disease
among men was higher than expected in the controls,composition of lithogenic factors may change over time.
The values for urine oxalate excretion for cases and but the mean 24-hour urine values were not materially
different after excluding controls with a family history.controls in males and females were much higher than in
most previous reports [15–17], but not all [2]. Possible Information on family history was not available for fe-
males. The frequencies of urinary abnormalities ob-explanations for these differences include differences in
dietary oxalate intake, different analytic methods, time served in the HPFS cohort may be different than in males
younger than 40 years of age. Our results are applicabletrends, and in vitro conversion of ascorbate to oxalate. In
our study, oxalate was measured by ion chromatography, to first-time stone formers in the observed age ranges.
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